Sr. Research Associate
- Employer
- AnaptysBio, Inc.
- Location
- San Diego, CA, US
- Start date
- Oct 15, 2019
View more
- Discipline
- Science/R&D, Research
- Required Education
- Bachelors Degree
- Position Type
- Full time
- Hotbed
- Biotech Beach
Job Details
This position reports to the Scientist II, Protein Sciences
Requirements
Education and Experience
- BA/BS degree in biology, biochemistry, or a related field
- 5+ years of relevant laboratory experience
- Strong background in kinetics (i.e. Surface Plasmon Resonance or Octet), especially working with antibodies. Experience with KinExA is a plus.
Knowledge and Competencies
- Working knowledge of antibody structure/function
- Experience with a range of analytical tools including all or some of the following techniques: SPR, ELISA, DSC, cIEF, CE-SDS, and DLS
- Familiarity with protein visualization software (i.e. PyMol, Discovery Studio, etc)
- Experience with enzyme kinetics is a plus
- Ability to communicate clearly, and to report and present experimental results and analysis to department colleagues
- Effective interpersonal skills, strong team player
- Ability to multitask, prioritize, and function in a fast-paced entrepreneurial environment
- Able to determine and validate new methods and procedures. Able to perform critical analysis of experimental approach and interpretation of data
- Demonstrated ability to perform laboratory tasks safely, reproducibly, and efficiently
- Ability to organize work load and activities to achieve team goals
Company
AnaptysBio is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics. We are developing immune cell modulators, including two checkpoint agonists in clinical-stage development, for autoimmune and inflammatory disease: rosnilimab, our PD-1 agonist program in a Phase 2 trial for the treatment of moderate-to-severe rheumatoid arthritis; and ANB032, our BTLA agonist program, currently in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis. Our preclinical immune cell modulator portfolio includes ANB033, an anti-CD122 antagonist antibody for the treatment of autoimmune and inflammatory diseases. In addition, AnaptysBio has developed two cytokine antagonists available for out-licensing: imsidolimab, an anti-IL-36R antagonist, in Phase 3 for the treatment of generalized pustular psoriasis, or GPP, and etokimab, an anti-IL-33 antagonist for the treatment of respiratory disorders that is Phase 2/3 ready. AnaptysBio has also discovered multiple therapeutic antibodies licensed to GSK in a financial collaboration for immune-oncology, including an anti-PD-1 antagonist antibody (Jemperli (dostarlimab-gxly)), an anti-TIM-3 antagonist antibody (cobolimab, GSK4069889) and an anti-LAG-3 antagonist antibody (GSK4074386).
Our corporate vision is to transform patient health by delivering innovative immunology therapeutics. Find out more about us by following us on Twitter.
CONNECT
- Website
- http://www.anaptysbio.com/
- Phone
- 858-362-6295
- Location
-
10770 Wateridge Circle
Suite 210
San Diego
California
92121
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert